89897-29-0 Usage
General Description
Pyrazole-4-carbonitrile, 3-amino-1-isopropyl- (7CI) is a chemical compound with the molecular formula C7H9N3. It is a pyrazole derivative with a substituted amino and isopropyl group. Pyrazole-4-carbonitrile, 3-amino-1-isopropyl- (7CI) has potential applications in pharmaceutical and chemical industries, specifically in the development of new drugs and agrochemicals. It may also be used as an intermediate in organic synthesis for the production of various other compounds. Additionally, the presence of the amino and isopropyl groups makes it a versatile building block for the synthesis of more complex organic molecules.
Check Digit Verification of cas no
The CAS Registry Mumber 89897-29-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,9,8,9 and 7 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 89897-29:
(7*8)+(6*9)+(5*8)+(4*9)+(3*7)+(2*2)+(1*9)=220
220 % 10 = 0
So 89897-29-0 is a valid CAS Registry Number.
InChI:InChI=1/C7H10N4/c1-5(2)11-4-6(3-8)7(9)10-11/h4-5H,1-2H3,(H2,9,10)
89897-29-0Relevant articles and documents
A facile and novel synthesis of N2-, C6-substituted pyrazolo[3,4- d ]pyrimidine-4 carboxylate derivatives as adenosine receptor antagonists
Venkatesan,Paira,Cheong,Federico,Klotz,Spalluto,Pastorin
, p. 784 - 798 (2015/02/05)
An efficient synthetic procedure was adopted to synthesize a series of new molecules containing the pyrazolo[3,4-d]pyrimidine (PP) scaffold, which have been evaluated as promising human adenosine receptor (AR) antagonists. The effect of substitutions at t
COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS
-
Page/Page column 40, (2011/04/14)
The invention provides a novel class of compounds of formula 1, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of B-Raf.
